Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

In vivo testing of novel GPR-directed [99mTc]demobesin mimics

Oct. 23, 2014

Pivotal study begins of BreathID test for clinically significant portal hypertension

Oct. 22, 2014

HMB-45 staining increases after UVB treatment for vitiligo

Oct. 21, 2014

U.S. orphan drug designation for radiotracer OPS-202

Oct. 17, 2014

ZERO Cancer Research Fund supports prostate cancer early detection work at UCSF

Oct. 17, 2014

FDA clears Lyra Parainfluenza Assay for use

Oct. 16, 2014

NanoLogix configuring N-Assay Rapid diagnostic kits for viruses

Oct. 16, 2014

FDA approves Quidel's Lyra Adenovirus Assay

Oct. 15, 2014

New Oncology and Gustave Roussy Cancer Campus collaborate on tumor genome profiling

Oct. 14, 2014

Biocept and Rosetta Genomics to evaluate microRNAs from circulating tumor cells

Oct. 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...